Science Market Update

USC Receives $3.3M to Improve Treatment of a Common Birth Defect

Posted by Emily Olson on Fri, Sep 23, 2016

The $3.3M research grant, given to a team of researchers at the University of Southern California, will support a project that will lead to improved treatment of craniosynostosis. Craniosynostosis is a birth defect that occurs in roughly one out of every 2,500 live births and in severe cases can lead to developmental delays, hearing loss, blindness, and even death. 

Read More

Tags: CA, University of Southern California, California, USC, Research Funding, NIH grant, Southwest Region, BioResearch Product Faire™, Birth Defects

$13M Grant for Ebola Virus Research at Washington University

Posted by Emily Olson on Wed, Sep 21, 2016

A team of researchers led by Gaya Amarasinghe, associate professor of Pathology and Immunology at Washington University School of Medicine, was recently awarded a $13 million NIH grant to study the replication process of the Ebola virus. 

Read More

Tags: Washington University St. Louis, Research Funding, MO, NIH grant, Midwest Region, ebola

UCLA: One Step Closer to the Cause of Autism

Posted by Rebecca Partridge on Mon, Sep 19, 2016

Over the last 40 years incidence of Autism Spectrum Disorder (ASD) have increased tenfold. Until recently, the cause of autism was a complete mystery. Now a major discovery at UCLA has just brought researchers one step closer to unlocking the mystery of ASD.

The UCLA study found distinctive changes in the levels of tiny regulator molecules known as microRNAs in the brains of people with ASD. These microRNAs control the activities of large gene networks. This finding helps explain why so many genes are abnormal in autism disorders. It could also lead to targeted treatments or preventative measures someday.

Read More

Tags: University of California Los Angeles, Biotech Event, UCLA, biomedical researh, autism research, mircoRNA, Dr. Daniel Geschwind

UC Irvine Breaks Research Funding Record

Posted by Emily Olson on Fri, Sep 16, 2016

For fiscal year 2015-16, UC Irvine received $395 million in grants and contracts and $132.5 million in philanthropic gifts, breaking the university's previous funding records in both areas. Fundraising doubled from the previous fiscal year and funding from research grants and contracts increased by more than $100 million.

Read More

Tags: University of California Irvine, University of California, Research Funding, Southwest Region, UCI, UC Irvine, BioResearch Product Faire™

Stony Brook University Receives $2.3M for Autism Research

Posted by Emily Olson on Wed, Sep 14, 2016

The National Institute of Mental Health recently awarded a $2.3M Biobehavioral Research Award for Innovative New Scientists (BRAINS) grant to Dr. Matthew D. Lerner, an assistant professor in the Department of Psychology at Stony Brook University. The grant will provide funding for Dr. Lerner's project, “Optimizing Prediction of Social Deficits in Autism Spectrum Disorders,” a study which aims to help youth with autism overcome social challenges.

Read More

Tags: Stony Brook University, Autism, Research Funding, NY, Northeast Region, NIH grant, Stony Brook, BioResearch Product Faire™

U of I at Chicago Receives $17.7 M Translational Research Grant

Posted by Rebecca Partridge on Fri, Sep 09, 2016

(Image courtesy of Wikimedia commons)

The National Institutes of Health (NIH) awarded a four year, $17.7 million grant to the university of Illinois at Chicago’s Center for Clinical and Transitional Science to further translational research.

Read More

Tags: University of Illinois, University of Illinois Chicago, Translational Research, University of Illinois at Chicago, Chicago, biotech vendor show, NIH award, UI Chicago, UIC, UIChgo, University of Illiniois, 2016, Bioresearch Grant

Researchers at Columbia University Find Ways to Reduce Damage Done by Strokes

Posted by Rebecca Partridge on Fri, Sep 02, 2016

 Researchers at the Columbia University Medical Center (CUMC) may have found a way to reduce brain damage caused by a stroke or stroke-like event.  In a study funded by the National Heart, Lung, and Blood Institute and the National Institute of Neurological Disorders and Stroke, 10-day-old mice that had an hypoxic (lack of oxygen) or ischemic (lack of blood) brain injury were treated with a fat emulsion containing either DHA or EPA—omega-3 fatty acids. The researchers evaluated the mice’s neurological function 24 hours and 8 to 9 weeks after the brain injury. They discovered that the mice treated with the DHA omega-3 fatty acids had a significant reduction in brain injury. This did not hold true for those treated with EPA-omega 3. The DHA group also had significantly better results in multiple brain functions during the 8 and 9 weeks evaluation compared to the EPA-treated mice and the control group which went untreated.

Read More

Tags: BioResearch Trade Show, New York, Columbia University, Columbia, NY, New York City, Columbia University Medical Center, biomedical researh, stroke, stroke research, DHA omega-3 fatty acids

Ohio State Researcher Finds Gene-Based Approach to Fight Fungus

Posted by BCI Staff on Wed, Aug 31, 2016

Although people expect to go to the hospital to be treated for their illnesses, sometimes patients can acquire fungal infections during treatment that can make them even sicker. The fungus Candida albicans is a common hospital-acquired fungus that can get into the bloodstream and vital organs, leading to a mortality rate of up to 75% of infected patients. Researchers at The Ohio State University in Columbus have found a potential approach to fight these infections.  

Read More

Tags: Ohio State University, Columbus, OH, OhStu, 2016, BioResearch Product Faire, Candida albicans

UCLA Researchers: New Evidence for Novel Method of Cancer Metastasis

Posted by Greg Paul on Fri, Aug 26, 2016

Researchers from UCLA and partnering schools guided by Laurent Bentolila found evidence supporting the spread of malignant cells through angiotropism with vascular co-option, and even suggested they may be related or identical processes.  These findings were published in Nature Scientific Reports. With angiotropism being the ability for cells to travel along surface of blood vessels, but not be inside of them, also called extravascular migratory metastasis (EVMM) and vascular co-option being the ability for a tumor to use a blood supply and travel along it, this means cancer has an outlet to spread outside of the bloodstream.  The spread outside of the bloodstream means some current methods of treating cancer would be ineffective.

“... if the metastasizing cells are on the outside of the blood vessels, they escape exposure to the treatment and continue to spread cancer.”

-Laurent A. Bentolila

Read More

Tags: CA, University of California Los Angeles, cancer research, Los Angeles, Cancer, LAVS, UCLA, laboratory, lab products, 2016

Laboratory Product Sales Opportunity: Early 2017 Pricing Ends Friday

Posted by BCI Staff on Thu, Aug 25, 2016

How much product can exhibiting companies sell at a single event? Let Biotechnology Calendar, Inc. help you find out! With the 2017 schedule out we can help you select the very best shows to increase your scientific product sales.

Read More

Tags: vendor show, Sales, scientific sales, Lab Supply, lab product, 2017, Early Release